VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
GPCR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
GPCRStructure Therapeutics Inc.
$20.35$1.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksGPCRQuarterly Financials

Structure Therapeutics Inc. (GPCR) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Structure Therapeutics Inc. (GPCR) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

GPCR Income Statement

Quarterly statement

GPCR Income Statement

Structure Therapeutics Inc. (GPCR) annual income statement — 6-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q1'22Q4'21
Sales/Revenue000000000000000000
Revenue Growth %------------------
Cost of Goods Sold01.22M0000000000000000
COGS % of Revenue------------------
Gross Profit0-1.22M0000000000000000
Gross Margin %------------------
Gross Profit Growth %------------------
Operating Expenses118.63M88.43M-23.99M73.79M70.45M56.31M47.06M45.84M33.32M32.02M30.99M26.14M25.99M19.65M12.96M12.69M12.95M13.27M
OpEx % of Revenue------------------
Selling, General & Admin18.57M22.87M17.57M14.8M15.74M13.44M13.57M13.24M11.27M11.34M10.95M8.63M6.58M6.51M4.6M3.53M4.46M3.37M
SG&A % of Revenue------------------
Research & Development100.06M66.71M68.69M58.99M54.71M42.87M33.49M32.6M22.05M20.68M20.04M17.52M19.41M13.13M8.36M9.16M8.49M9.91M
R&D % of Revenue------------------
Other Operating Expenses0-1000K-1000K000000000000000
Operating Income-118.63M-89.65M23.99M-73.79M-70.45M-56.31M-47.06M-45.84M-33.32M-32.02M-30.99M-26.14M-25.99M-19.65M-12.96M-12.69M-12.95M-13.27M
Operating Margin %------------------
Operating Income Growth %-68.39%-59.2%150.97%-60.98%-111.46%-75.89%-51.84%-75.31%-28.2%-62.93%-139.23%-105.98%------
EBITDA-118.08M-89.07M24.4M-73.43M-70.16M-56.04M-46.79M-45.57M-33.08M-31.79M-30.92M-26.07M-25.91M-19.58M-12.88M-12.62M-12.88M-13.21M
EBITDA Margin %------------------
EBITDA Growth %-68.3%-58.95%152.15%-61.14%-112.07%-76.26%-51.31%-74.83%-27.67%-62.38%-140%-106.59%------
D&A (Non-Cash Add-back)551K576K412K356K291K274K273K265K232K222K72K79K74K70K72K76K70K66K
EBIT-105.92M-76M33.17M-65.6M-61.52M-46.73M-36.34M-33.88M-25.98M-26.01M-30.99M-26.14M-25.99M-19.65M-12.96M-12.69M-12.95M-13.27M
Net Interest Income013.64M18.55M08.96M9.58M10.72M07.33M6M6.22M2.69M2.79M1.7M901K349K-69K-1K
Interest Income013.64M18.55M08.96M9.59M10.68M07.33M6M6.22M2.69M2.79M1.7M899.51K349K02
Interest Expense000000000000000069K1K
Other Income/Expense12.71M13.64M9.19M8.18M8.93M9.58M10.72M11.95M7.33M6.01M6.18M2.69M2.83M1.7M901K349K-69K-1K
Pretax Income-105.92M-76M33.17M-65.6M-61.52M-46.73M-36.34M-33.88M-25.98M-26.01M-24.82M-23.46M-23.16M-17.95M-12.05M-12.34M-13.02M-13.28M
Pretax Margin %------------------
Income Tax234K190.57K170K108K139K98K136K92K53K29K-312K405K118K25K-180K73K60K81K
Effective Tax Rate %-0.22%-0.25%0.51%-0.16%-0.23%-0.21%-0.37%-0.27%-0.2%-0.11%1.26%-1.73%-0.51%-0.14%1.49%-0.59%-0.46%-0.61%
Net Income-106.16M-76.19M33M-65.71M-61.66M-46.83M-36.48M-33.98M-26.03M-26.04M-24.5M-23.86M-23.28M-17.98M-10.36M-12.42M-13.08M-15.43M
Net Margin %------------------
Net Income Growth %-72.17%-62.69%190.47%-93.4%-136.85%-79.88%-48.88%-42.39%-11.83%-44.85%-136.52%-92.17%------
Net Income (Continuing)-106.16M-76.19M33M-65.71M-61.66M-46.83M-36.48M-33.98M-26.03M-26.04M-24.5M-23.86M-23.28M-17.98M-11.88M-12.42M-13.08M-13.36M
Discontinued Operations000000000000000000
Minority Interest000000000000000000
EPS (Diluted)-1.47-1.050.60-1.11-1.08-0.81-0.63-0.60-0.54-0.57-0.54-0.63-0.60-0.48-0.32-1.27-0.36-0.42
EPS Growth %-36.11%-29.63%195.24%-85%-100%-42.11%-16.67%4.76%10%-18.75%-68.75%50.39%------
EPS (Basic)-1.47-1.050.60-1.11-1.08-0.81-0.63-0.60-0.54-0.57-0.54-0.63-0.60-0.48-0.32-1.27-0.36-0.42
Diluted Shares Outstanding72.65M72.44M59.2M58.49M57.92M57.35M57.29M57.21M49.41M46.57M46.41M38.32M38.25M37.42M36.59M39.12M36.59M36.59M
Basic Shares Outstanding72.65M72.44M59.2M58.49M57.92M57.35M57.29M57.21M49.41M46.57M46.41M38.32M38.25M37.42M36.59M39.12M36.59M36.59M
Dividend Payout Ratio------------------